Glucocorticoid-resistant asthma. T-lymphocyte defects (Q41075203)

26 September 2017

1 reference

title

Glucocorticoid-resistant asthma. T-lymphocyte defects (English)

1 reference

26 September 2017

0 references

0 references

Corrigan CJ

1

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

American Journal of Respiratory and Critical Care Medicine

26 September 2017

published in

1 reference

26 September 2017

volume

154

1 reference

26 September 2017

issue

2 Pt 2

1 reference

26 September 2017

page(s)

S53-5; discussion S55-7

1 reference

On observing patterns of airflow obstruction in chronic asthma

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Steroid resistance in asthma: our current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Steroid-resistant asthma: immunologic and pharmacologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

Cutaneous vasoconstrictor response to glucocorticoids in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F154.2_PT_2.S53

10.1164/AJRCCM/154.2_PT_2.S53

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference